17 July 2024 : Clinical Research
Prognostic Impact of Tumor-Infiltrating Immune Cells on Efficacy of Neoadjuvant Chemotherapy in Patients with Advanced or Metastatic Ovarian Cancer: A Retrospective Study
Qunxian Rao1BCE, Miaoling Huang1B, Meimei Guan1C, Changhao Liu1D, Lijuan Wang1D, Zhongqiu Lin1A*, Qing Chen1ADOI: 10.12659/MSM.943170
Med Sci Monit 2024; 30:e943170
Figure 2 The associations of TIL subsets at diagnosis with the efficacy of NACT in advanced OVCA patients.(A) The association of density or positive rate of intratumoral CD56+ cells at diagnosis with the efficacy of NACT; (B) The association of density or positive rate of intratumoral M2-like macrophages (CD68+ CD168+) at diagnosis with the efficacy of NACT; (C) The association of density or positive rate of stromal M2-like macrophages (CD68+ CD168+) at diagnosis with the efficacy of NACT. NACT – neoadjuvant chemotherapy. Figure 2 was plotted by R version 4.0.0 (https://www.r-project.org/).